CT angiography works as well as conventional digital subtraction angiography for diagnosing peripheral arterial disease (PAD), researchers reported online in the journal Radiology.
CT angiography works as well as conventional digital subtraction angiography for diagnosing peripheral arterial disease (PAD), researchers reported online in the journal Radiology.
PAD, often a result of atherosclerosis, affects 15 to 20 percent of those over 70, particularly among men, former smokers, and those with diabetes.
An Italian team led by Alessandro Napoli, MD, PhD, of the University of Rome La Sapienza, considered results from 212 patients with symptomatic PAD who underwent 64-section CT angiography and then digital subtraction angiography, or DSA. To analyze arteries with stenosis of 70 percent or greater, the researchers divided the arterial bed into 35 segments, which were then evaluated by three readers.
Evaluating 7,420 segments in all, the team found agreement across the imaging methods in 96 percent of cases and an accuracy of 98 percent for both. They found “no significant difference between CT angiographic and DSA findings,” Napoli and colleagues reported.
Of the patients, 49 patients were referred for conservative treatment, 87 underwent endovascular procedures, 38 underwent surgery, and 17 received hybrid treatment. The therapy recommendations based on CT angiography imaging were identical to those based on DSA findings in all but one patient, the team said, concluding that “The diagnostic performance of 64-section CT angiography is excellent in patients with clinical symptoms of PAD.”
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.